Fundraising Fox

Biotech Investors & VC Firms in United States

563 firms in this list, with a median first check of $500K. 45 of them lead rounds. Generated from verified public data and updated continuously.

Norwest Venture Partners
Palo AltoGrowth
2 people
Casdin Capital
New YorkSeed–Series C
38 people
Longwood Fund
BostonSeed–Series B
23 people
GroveStreet
NewtonSeries A–Late Stage
39 people
Apple Tree Venture Management Llc
New YorkPre-Seed–Late Stage
20 people
Cultivation Capital
St. LouisSeed–Series B$100K – $3.5M
32 people
Artis Ventures
San FranciscoSeed–Late Stage
5 people
Lightstone Ventures
Portola ValleyPre-Seed–Late Stage
22 people
Advent International
BostonSeries A–Late Stage$1.1B
36 people
Longitude Capital
Menlo ParkSeries A–Late Stage$10M – $30M
36 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
35 people
UTEC
TokyoPre-Seed–Growth
11 people
Cortado Ventures
Oklahoma CitySeed
18 people
GreatPoint Ventures
San FranciscoSeed–Series B$250K – $20M
11 people
Atlas Venture
CambridgeSeed–Late Stage
16 people
Alpha Edison
Los AngelesSeed–Series A
12 people
Sustainable Food Ventures
SeattlePre-Seed–Series A
3 people
Faber
LisbonPre-Seed–Series A$2.8M
17 people
RiverVest Venture Partners
St. LouisPre-Seed–Late Stage$500K – $3M
13 people
Two Bear Capital
WhitefishPre-Seed–Series B$3M – $10M
24 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
36 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
22 people
Celesta Capital
San MateoSeed–Late Stage
7 people
AgFunder
San FranciscoSeed–Growth
31 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.